 | • レポートコード：GIR201107463 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、処方用皮膚科薬品の世界市場を調査対象にし、処方用皮膚科薬品の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（経口、局所）、用途別分析（病院薬局、オンライン薬局、小売薬局）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Mylan Pharmaceuticals、Galderma、Bausch Health、Pfizer、Bristol-Myers Squibb、Almirall、PharmaDerm、Barrier Therapeutics、Novartis ・メーカー別販売量、売上、市場シェア ・処方用皮膚科薬品の地域別市場分析 ・処方用皮膚科薬品の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・処方用皮膚科薬品のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・処方用皮膚科薬品のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・処方用皮膚科薬品の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・処方用皮膚科薬品の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・処方用皮膚科薬品の種類別市場規模2015-2020：経口、局所 ・処方用皮膚科薬品の用途別市場規模2015-2020：病院薬局、オンライン薬局、小売薬局 ・処方用皮膚科薬品の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Prescription Dermatological Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Prescription Dermatological Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Prescription Dermatological Medications market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Prescription Dermatological Medications market has been segmented into
Oral
Topical
By Application, Prescription Dermatological Medications has been segmented into:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Prescription Dermatological Medications market presented in the report. This section sheds light on the sales growth of different regional and country-level Prescription Dermatological Medications markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prescription Dermatological Medications market.
The report offers in-depth assessment of the growth and other aspects of the Prescription Dermatological Medications market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Prescription Dermatological Medications Market Share Analysis
Prescription Dermatological Medications competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prescription Dermatological Medications sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prescription Dermatological Medications sales, revenue and market share for each player covered in this report.
The major players covered in Prescription Dermatological Medications are:
Mylan Pharmaceuticals
Galderma
Bausch Health
Pfizer
Bristol-Myers Squibb
Almirall
PharmaDerm
Barrier Therapeutics
Novartis
Among other players domestic and global, Prescription Dermatological Medications market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prescription Dermatological Medications product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prescription Dermatological Medications, with price, sales, revenue and global market share of Prescription Dermatological Medications in 2018 and 2019.
Chapter 3, the Prescription Dermatological Medications competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prescription Dermatological Medications breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Prescription Dermatological Medications market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Prescription Dermatological Medications sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Prescription Dermatological Medications Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prescription Dermatological Medications Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oral
1.2.3 Topical
1.3 Market Analysis by Application
1.3.1 Overview: Global Prescription Dermatological Medications Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Overview of Global Prescription Dermatological Medications Market
1.4.1 Global Prescription Dermatological Medications Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Mylan Pharmaceuticals
2.1.1 Mylan Pharmaceuticals Details
2.1.2 Mylan Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Mylan Pharmaceuticals SWOT Analysis
2.1.4 Mylan Pharmaceuticals Product and Services
2.1.5 Mylan Pharmaceuticals Prescription Dermatological Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Galderma
2.2.1 Galderma Details
2.2.2 Galderma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Galderma SWOT Analysis
2.2.4 Galderma Product and Services
2.2.5 Galderma Prescription Dermatological Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bausch Health
2.3.1 Bausch Health Details
2.3.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bausch Health SWOT Analysis
2.3.4 Bausch Health Product and Services
2.3.5 Bausch Health Prescription Dermatological Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Prescription Dermatological Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bristol-Myers Squibb SWOT Analysis
2.5.4 Bristol-Myers Squibb Product and Services
2.5.5 Bristol-Myers Squibb Prescription Dermatological Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Almirall
2.6.1 Almirall Details
2.6.2 Almirall Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Almirall SWOT Analysis
2.6.4 Almirall Product and Services
2.6.5 Almirall Prescription Dermatological Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 PharmaDerm
2.7.1 PharmaDerm Details
2.7.2 PharmaDerm Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 PharmaDerm SWOT Analysis
2.7.4 PharmaDerm Product and Services
2.7.5 PharmaDerm Prescription Dermatological Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Barrier Therapeutics
2.8.1 Barrier Therapeutics Details
2.8.2 Barrier Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Barrier Therapeutics SWOT Analysis
2.8.4 Barrier Therapeutics Product and Services
2.8.5 Barrier Therapeutics Prescription Dermatological Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Novartis SWOT Analysis
2.9.4 Novartis Product and Services
2.9.5 Novartis Prescription Dermatological Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Prescription Dermatological Medications Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Prescription Dermatological Medications Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Prescription Dermatological Medications Manufacturer Market Share in 2019
3.3.2 Top 6 Prescription Dermatological Medications Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Prescription Dermatological Medications Sales, Revenue and Market Share by Regions
4.1.1 Global Prescription Dermatological Medications Sales and Market Share by Regions (2015-2020)
4.1.2 Global Prescription Dermatological Medications Revenue and Market Share by Regions (2015-2020)
4.2 North America Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
4.3 Europe Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
4.5 South America Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Prescription Dermatological Medications Sales, Revenue and Market Share by Country
5.1.1 North America Prescription Dermatological Medications Sales and Market Share by Country (2015-2020)
5.1.2 North America Prescription Dermatological Medications Revenue and Market Share by Country (2015-2020)
5.2 United States Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
5.3 Canada Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
5.4 Mexico Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Prescription Dermatological Medications Sales, Revenue and Market Share by Country
6.1.1 Europe Prescription Dermatological Medications Sales and Market Share by Country (2015-2020)
6.1.2 Europe Prescription Dermatological Medications Revenue and Market Share by Country (2015-2020)
6.2 Germany Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
6.3 UK Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
6.4 France Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
6.5 Russia Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
6.6 Italy Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Prescription Dermatological Medications Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Prescription Dermatological Medications Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Prescription Dermatological Medications Revenue and Market Share by Regions (2015-2020)
7.2 China Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
7.3 Japan Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
7.4 Korea Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
7.5 India Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
7.7 Australia Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Prescription Dermatological Medications Sales, Revenue and Market Share by Country
8.1.1 South America Prescription Dermatological Medications Sales and Market Share by Country (2015-2020)
8.1.2 South America Prescription Dermatological Medications Revenue and Market Share by Country (2015-2020)
8.2 Brazil Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
8.3 Argentina Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Prescription Dermatological Medications Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Prescription Dermatological Medications Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Prescription Dermatological Medications Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
9.3 Turkey Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
9.4 Egypt Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
9.5 South Africa Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Prescription Dermatological Medications Sales and Market Share by Type (2015-2020)
10.2 Global Prescription Dermatological Medications Revenue and Market Share by Type (2015-2020)
10.3 Global Prescription Dermatological Medications Price by Type (2015-2020)
11 Global Prescription Dermatological Medications Market Segment by Application
11.1 Global Prescription Dermatological Medications Sales Market Share by Application (2015-2020)
11.2 Global Prescription Dermatological Medications Revenue Market Share by Application (2015-2020)
11.3 Global Prescription Dermatological Medications Price by Application (2015-2020)
12 Market Forecast
12.1 Global Prescription Dermatological Medications Sales, Revenue and Growth Rate (2021-2025)
12.2 Prescription Dermatological Medications Market Forecast by Regions (2021-2025)
12.2.1 North America Prescription Dermatological Medications Market Forecast (2021-2025)
12.2.2 Europe Prescription Dermatological Medications Market Forecast (2021-2025)
12.2.3 Asia-Pacific Prescription Dermatological Medications Market Forecast (2021-2025)
12.2.4 South America Prescription Dermatological Medications Market Forecast (2021-2025)
12.2.5 Middle East & Africa Prescription Dermatological Medications Market Forecast (2021-2025)
12.3 Prescription Dermatological Medications Market Forecast by Type (2021-2025)
12.3.1 Global Prescription Dermatological Medications Sales Forecast by Type (2021-2025)
12.3.2 Global Prescription Dermatological Medications Market Share Forecast by Type (2021-2025)
12.4 Prescription Dermatological Medications Market Forecast by Application (2021-2025)
12.4.1 Global Prescription Dermatological Medications Sales Forecast by Application (2021-2025)
12.4.2 Global Prescription Dermatological Medications Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Prescription Dermatological Medications Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Prescription Dermatological Medications by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Prescription Dermatological Medications Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Mylan Pharmaceuticals Prescription Dermatological Medications Major Business
Table 9. Mylan Pharmaceuticals Prescription Dermatological Medications Total Revenue (USD Million) (2018-2019)
Table 10. Mylan Pharmaceuticals SWOT Analysis
Table 11. Mylan Pharmaceuticals Prescription Dermatological Medications Product and Services
Table 12. Mylan Pharmaceuticals Prescription Dermatological Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Galderma Basic Information, Manufacturing Base and Competitors
Table 14. Galderma Prescription Dermatological Medications Major Business
Table 15. Galderma Prescription Dermatological Medications Total Revenue (USD Million) (2018-2019)
Table 16. Galderma SWOT Analysis
Table 17. Galderma Prescription Dermatological Medications Product and Services
Table 18. Galderma Prescription Dermatological Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 20. Bausch Health Prescription Dermatological Medications Major Business
Table 21. Bausch Health Prescription Dermatological Medications Total Revenue (USD Million) (2018-2019)
Table 22. Bausch Health SWOT Analysis
Table 23. Bausch Health Prescription Dermatological Medications Product and Services
Table 24. Bausch Health Prescription Dermatological Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Prescription Dermatological Medications Major Business
Table 27. Pfizer Prescription Dermatological Medications Total Revenue (USD Million) (2018-2019)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Prescription Dermatological Medications Product and Services
Table 30. Pfizer Prescription Dermatological Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 32. Bristol-Myers Squibb Prescription Dermatological Medications Major Business
Table 33. Bristol-Myers Squibb Prescription Dermatological Medications Total Revenue (USD Million) (2018-2019)
Table 34. Bristol-Myers Squibb SWOT Analysis
Table 35. Bristol-Myers Squibb Prescription Dermatological Medications Product and Services
Table 36. Bristol-Myers Squibb Prescription Dermatological Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Almirall Basic Information, Manufacturing Base and Competitors
Table 38. Almirall Prescription Dermatological Medications Major Business
Table 39. Almirall Prescription Dermatological Medications Total Revenue (USD Million) (2018-2019)
Table 40. Almirall SWOT Analysis
Table 41. Almirall Prescription Dermatological Medications Product and Services
Table 42. Almirall Prescription Dermatological Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. PharmaDerm Basic Information, Manufacturing Base and Competitors
Table 44. PharmaDerm Prescription Dermatological Medications Major Business
Table 45. PharmaDerm Prescription Dermatological Medications Total Revenue (USD Million) (2018-2019)
Table 46. PharmaDerm SWOT Analysis
Table 47. PharmaDerm Prescription Dermatological Medications Product and Services
Table 48. PharmaDerm Prescription Dermatological Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Barrier Therapeutics Basic Information, Manufacturing Base and Competitors
Table 50. Barrier Therapeutics Prescription Dermatological Medications Major Business
Table 51. Barrier Therapeutics Prescription Dermatological Medications Total Revenue (USD Million) (2018-2019)
Table 52. Barrier Therapeutics SWOT Analysis
Table 53. Barrier Therapeutics Prescription Dermatological Medications Product and Services
Table 54. Barrier Therapeutics Prescription Dermatological Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Novartis Basic Information, Manufacturing Base and Competitors
Table 56. Novartis Prescription Dermatological Medications Major Business
Table 57. Novartis Prescription Dermatological Medications Total Revenue (USD Million) (2018-2019)
Table 58. Novartis SWOT Analysis
Table 59. Novartis Prescription Dermatological Medications Product and Services
Table 60. Novartis Prescription Dermatological Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Prescription Dermatological Medications Sales by Manufacturer (2018-2019) (K Units)
Table 62. Global Prescription Dermatological Medications Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Prescription Dermatological Medications Sales by Regions (2015-2020) (K Units)
Table 64. Global Prescription Dermatological Medications Sales Market Share by Regions (2015-2020)
Table 65. Global Prescription Dermatological Medications Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Prescription Dermatological Medications Sales by Countries (2015-2020) (K Units)
Table 67. North America Prescription Dermatological Medications Sales Market Share by Countries (2015-2020)
Table 68. North America Prescription Dermatological Medications Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Prescription Dermatological Medications Revenue Market Share by Countries (2015-2020)
Table 70. Europe Prescription Dermatological Medications Sales by Countries (2015-2020) (K Units)
Table 71. Europe Prescription Dermatological Medications Sales Market Share by Countries (2015-2020)
Table 72. Europe Prescription Dermatological Medications Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Prescription Dermatological Medications Sales by Regions (2015-2020) (K Units)
Table 74. Asia-Pacific Prescription Dermatological Medications Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Prescription Dermatological Medications Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Prescription Dermatological Medications Sales by Countries (2015-2020) (K Units)
Table 77. South America Prescription Dermatological Medications Sales Market Share by Countries (2015-2020)
Table 78. South America Prescription Dermatological Medications Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Prescription Dermatological Medications Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Prescription Dermatological Medications Sales by Countries (2015-2020) (K Units)
Table 81. Middle East & Africa Prescription Dermatological Medications Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Prescription Dermatological Medications Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Prescription Dermatological Medications Revenue Market Share by Countries (2015-2020)
Table 84. Global Prescription Dermatological Medications Sales by Type (2015-2020) (K Units)
Table 85. Global Prescription Dermatological Medications Sales Share by Type (2015-2020)
Table 86. Global Prescription Dermatological Medications Revenue by Type (2015-2020) (USD Million)
Table 87. Global Prescription Dermatological Medications Revenue Share by Type (2015-2020)
Table 88. Global Prescription Dermatological Medications Sales by Application (2015-2020) (K Units)
Table 89. Global Prescription Dermatological Medications Sales Share by Application (2015-2020)
Table 90. Global Prescription Dermatological Medications Sales Forecast by Regions (2021-2025) (K Units)
Table 91. Global Prescription Dermatological Medications Market Share Forecast by Regions (2021-2025)
Table 92. Global Prescription Dermatological Medications Sales Forecast by Type (2021-2025) (K Units)
Table 93. Global Prescription Dermatological Medications Market Share Forecast by Type (2021-2025)
Table 94. Global Prescription Dermatological Medications Sales Forecast by Application (2021-2025)
Table 95. Global Prescription Dermatological Medications Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Prescription Dermatological Medications Picture
Figure 2. Global Sales Market Share of Prescription Dermatological Medications by Type in 2019
Figure 3. Oral Picture
Figure 4. Topical Picture
Figure 5. Prescription Dermatological Medications Sales Market Share by Application in 2018
Figure 6. Hospital Pharmacies Picture
Figure 7. Online Pharmacies Picture
Figure 8. Retail Pharmacies Picture
Figure 9. Global Prescription Dermatological Medications Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Prescription Dermatological Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Prescription Dermatological Medications Sales Market Share by Manufacturer in 2019
Figure 30. Global Prescription Dermatological Medications Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Prescription Dermatological Medications Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Prescription Dermatological Medications Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Prescription Dermatological Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Prescription Dermatological Medications Revenue Market Share by Regions (2015-2020)
Figure 37. Global Prescription Dermatological Medications Revenue Market Share by Regions in 2018
Figure 38. North America Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
Figure 39. Europe Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
Figure 41. South America Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Prescription Dermatological Medications Sales and Growth Rate (2015-2020)
Figure 43. North America Prescription Dermatological Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Prescription Dermatological Medications Sales Market Share by Countries (2015-2020)
Figure 45. North America Prescription Dermatological Medications Sales Market Share by Countries in 2018
Figure 46. North America Prescription Dermatological Medications Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Prescription Dermatological Medications Revenue Market Share by Countries in 2018
Figure 48. United States Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Prescription Dermatological Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Prescription Dermatological Medications Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Prescription Dermatological Medications Revenue Market Share by Countries in 2019
Figure 54. Germany Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Prescription Dermatological Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Prescription Dermatological Medications Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Prescription Dermatological Medications Revenue Market Share by Regions 2019
Figure 62. China Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Prescription Dermatological Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Prescription Dermatological Medications Sales Market Share by Countries in 2019
Figure 69. South America Prescription Dermatological Medications Revenue Market Share by Countries in 2019
Figure 70. Brazil Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Prescription Dermatological Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Prescription Dermatological Medications Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Prescription Dermatological Medications Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Prescription Dermatological Medications Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Prescription Dermatological Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Prescription Dermatological Medications Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Prescription Dermatological Medications Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Prescription Dermatological Medications Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Prescription Dermatological Medications Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Prescription Dermatological Medications Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Prescription Dermatological Medications Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Prescription Dermatological Medications Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
皮膚疾患治療薬の世界市場 2020年 Market Overview The global Dermatological Disorders Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dermatol…- 処方用関節炎薬の世界市場 2020年 Market Overview The global Prescription Arthritis Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prescripti…
- 処方用整形外科薬品の世界市場 2020年 Market Overview The global Prescription Orthopedic Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prescription Or…
- 処方用胃腸薬の世界市場 2020年 Market Overview The global Prescription Gastrointestinal Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prescript…
- 処方用呼吸器治療薬の世界市場 2020年 Market Overview The global Prescription Respiratory Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prescription R…